Pharmaceutical Industry - Business Intelligence (BI) Analysis Case Study in the Pharmaceutical Industry_Solution Provider Co., Ltd._Beijing Pake Data Technology Co., Ltd.
 
Product Classification Co., Ltd.

Contact Information
  • Contact person:李经理
  • Telephone:010-85399411
  • Email:public@packingdata.com
  • Mobile:18733105738
  • Fax:官网:www.packingdata.com


Company Information

Location:Beijing

Shop Level: VIP

Business Model:Manufacturer, Service Provider

地址:No. 2, Chenjialin, Gaobeidian, Chaoyang District, Beijing, Room 306, 3rd Floor, Building A, Lianxin International Building

联系方式: 18733105738

Business Card

Beijing Pake Data Technology Co., Ltd.

  • 联系人:李经理 (女士) 
  • 电话:010-85399411
  • 手机:18733105738
  • 地址:No. 2, Chenjialin, Gaobeidian, Chaoyang District, Beijing, Room 306, 3rd Floor, Building A, Lianxin International Building
Home > Solution Provider Co., Ltd. > Pharmaceutical Industry - Business Intelligence (BI) Analysis Case Study in the Pharmaceutical Industry
Solution Provider Co., Ltd.
Pharmaceutical Industry - Business Intelligence (BI) Analysis Case Study in the Pharmaceutical Industry
Publish Time:2024-12-05        View Count:20         Return to List

Opening Remarks


In recent years, the value of data has continued to rise for businesses, leading to an increasing emphasis on data governance and analysis. With the advancement of digital transformation, Business Intelligence (BI) has become a hot topic. But what exactly is BI? What is BI analysis? Below, PK Data will explain using the healthcare and pharmaceutical sectors as a case study.


It's no secret that in China's manufacturing sector, there's a significant lag in the focus on technology compared to management. The primary reason is that for years, companies have prioritized copying multinational pharmaceuticals and employing various methods to sell drugs. However, with the country's strict management of new drug registration and review, the implementation of GMP (Good Manufacturing Practices), and stringent control over commercial bribery, companies that continue to operate in the old ways will find their market competitiveness diminishing. In essence, whether it's the pharmaceutical industry or other businesses, the core is the same: developing a great product (R&D), producing it at a certain cost (operations), and selling it at a good price (marketing).


Research and marketing are often the key focus areas for businesses, and they are generally well-regarded. However, when it comes to operations, the level of attention is insufficient. In reality, operations, as a value-added stage of products, require effective management. It's encouraging to see that an increasing number of companies are adopting new management approaches and ideas, such as lean production, business intelligence BI, and data-driven operations, to improve both performance and capabilities. Only when a company has established its ability for continuous improvement can it consistently address problems and achieve results. The construction of capabilities must be concurrent with performance enhancement; focusing solely on performance without building capabilities is unsustainable. Similarly, a company that focuses only on capability building without improving performance will lack competitiveness.


The improvement in operational management performance in the pharmaceutical industry is generally reflected through clear KPI metrics. Below are some BI analysis case studies that PK Data has accumulated in the pharmaceutical sector.


PakData - Business Intelligence BI Management Analysis Case Study in the Medical & Pharmaceutical Industry


Business Analysis Architecture


Product Pure Sales Analysis


MTD/QTD/YTD achievement rates, gross sales indicators, actual completion, year-on-year growth rates, key brand gross sales analysis, interlinkable to regions


Product Shipment Analysis


MTD/QTD/YTD achievement rates, shipment targets, actual completion, year-on-year growth rates, key brand shipment proportion analysis, and regional linkage


Regional Pure Sales and Hospital Development Contribution Analysis


Regional Pure Sales Ranking, Analysis of Regional Pure Sales and Hospital Contribution Trends, Top N Regional Pure Sales Ranking and Trend Analysis


Blank Hospital Develops Analysis


Successfully developed hospital numbers, contribution of new hospital sales, overall sales volume and trend analysis, etc.


Product Pure Sales Achievement Analysis


Blank Hospital Development Progress


Analysis of Abnormal Purchase and Return Situations in Hospitals - Key Indicators


Analysis of Abnormal Purchase and Return Cases in Hospital - Exceptional Warning


Dealer Inventory Analysis - Tier 1 Dealers, Tier 2 Dealers


Dealer Regional Distribution, Regional Dealer Inventory Ranking Analysis


Assessment Data Analysis


Market Competitor Analysis


Pure Sales Visualization Dashboard Analysis


• Comprehensive display of pure sales indicators and completion status, view by month, quarter, or year.


•Quickly grasp the pure sales indicator completion status across various sales regions.


• Quickly grasp the pure sales performance of various brands.


• Analyze the performance of net sales indicators through multi-dimensional combinations of time, sales regions, and brands.


Product Dispatch Visualization Dashboard Analysis


• Comprehensive display of MTD/QTD/YTD shipment status.


• View shipment indicators and actual shipment completion by dimensions such as time, region, brand, and product.


Blank Hospital Develops Visual Big Screen Analysis


•Comprehensive display of the number of blank hospital developments achieved at different time points and regions, the completion status of annual targets, and cumulative net sales for the year.


Staff Performance Dashboard Analysis


• Regional Sales Team's MTD/QTD/YTD Sales Analysis


• Regional Sales Representatives' Rankings


• Sales performance of regional sales staff, achievement analysis of key indicators, etc.


Conclusion


In March 2019, the State Council's government work report proposed to accelerate the development of "Internet+Medical Health" and the rapid expansion of telemedicine and pharmaceutical service systems. Currently, China's pharmaceutical industry is facing transformational pressures under policy guidance, with the main pain points of the traditional pharmaceutical industry being the overly single business model, lagging online supervision, and inadequate supply chain management. There is an urgent need for internet-based pharmaceutical industry collaboration and innovation to optimize information flow. In the future, pharmaceutical industry internet enterprises, leveraging their empowerment of the entire pharmaceutical industry chain and supported by emerging technologies such as AI and big data, will work alongside internet medical services and internet insurance services to construct a full-ecosystem closed loop of "Medical + Pharmaceutical + Insurance" in the field of big health.


According to relevant surveys, sixty percent of respondents believe that the level of informatization is crucial for the development of pharmaceutical companies. By means of informatization and digitalization, pharmaceutical companies can optimize and upgrade their industrial structures. Enhanced informatization levels can promote standardization in the pharmaceutical industry, optimize internal work processes, alleviate the workload of some company employees, and enhance the overall efficiency of the company.


*Excerpts from iResearch's "China's Healthcare and Pharmaceutical Industry Internet White Paper" are included above.*


Title: Healthcare & Pharmaceutical Industry BI Analysis Case - Business and Management Analysis


Thank you for watching! For more information, please contact us!


Phone Consultation

Consultation Phone:
010-85399411

QQ Service

QQ Service:
2959783

Back to Top